deltatrials
Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02617199

Epidural Anesthesia in Acute Pancreatitis

Epidural Anesthesia as an Alternative for Management in Acute Pancreatitis, a Randomised Clinical Trial

Sponsor: Hospital General Naval de Alta Especialidad - Escuela Medico Naval

Updated 8 times since 2017 Last updated: Jan 7, 2016 Started: Nov 30, 2015 Primary completion: Dec 31, 2016 Completion: Feb 28, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02617199, this PHASE2/PHASE3 trial focuses on Acute Pancreatitis and remains ongoing. Sponsored by Hospital General Naval de Alta Especialidad - Escuela Medico Naval, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Study Description(click to expand)

The main objective of the study is to evaluate the therapeutic effects of epidural block in patients with acute pancreatitis, comparing day hospital stay among patients receiving intravenous analgesic treatment and patients who are undergoing epidural block. It is a (prospective, comparative, longitudinal, experimental, randomized) controlled clinical trial. They include patients who are diagnosed with acute pancreatitis at the Naval General Hospital of High Specialty. Two groups were taken by random assignment.

The main objective of the study is to evaluate the therapeutic effects of epidural block in patients with acute pancreatitis, comparing day hospital stay among patients receiving intravenous analgesic treatment and patients who are undergoing epidural block.

It is a (prospective, comparative, longitudinal, experimental, randomized) controlled clinical trial. They include patients who are diagnosed with acute pancreatitis at the Naval General Hospital of High Specialty. Two groups were taken by random assignment.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Feb 2018 · 12 months · monthly snapshotRecruiting~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 19 months · monthly snapshotUnknown~Jan 2026 – present · 3 months · monthly snapshotUnknown

Change History

8 versions recorded
  1. Jan 2026 — Present [monthly]

    Unknown PHASE2/PHASE3

  2. Sep 2024 — Present [monthly]

    Unknown PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2/PHASE3

    Status: Unknown StatusUnknown · Phase: PHASE2_PHASE3PHASE2/PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2_PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2_PHASE3

Show 3 earlier versions
  1. Feb 2018 — Jun 2018 [monthly]

    Unknown Status PHASE2_PHASE3

    Status: RecruitingUnknown Status

  2. Feb 2017 — Feb 2018 [monthly]

    Recruiting PHASE2_PHASE3

  3. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2_PHASE3

    First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hospital General Naval de Alta Especialidad - Escuela Medico Naval
Data source: Hospital General Naval de Alta Especialidad - Escuela Medico Naval

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations